Chitosan microcapsule membranes with nanoscale thickness for controlled release of drugs.

In this paper, chitosan microcapsules with stable nano-membranes for controlled release of drugs are prepared by a simple one-step microfluidic strategy from oil-in-water (O/W) single emulsion templates. The ultrathin membranes of microcapsules are formed at the interface of the O/W emulsion droplets via the interfacial reaction between chitosan in aqueous phase and terephthalaldehyde in oil core. The membrane thickness can be effectively controlled within 10 nm and accurately regulated at nanoscale from 2.8 nm to 8.0 nm by adjusting the crosslinking time, concentrations of reactant and viscosity of aqueous solution. Among these factors, the membrane thickness is more susceptible to the viscosity of aqueous phase. The stability of the nano-membranes is quite good, which makes the microcapsules exhibit excellent structure integrity during 150 days. Using tea tree oil (TTO) as the model drug, the prepared chitosan microcapsules with nano-membranes show low mass transfer resistance and rapid drug release. The cumulative release rate of TTO from chitosan microcapsules with membrane thickness of 3.1 nm and 4.3 nm reach to 76.1% and 56.6% within 10 h, respectively. The drug release behaviors from the chitosan microcapsules are directly related to the thickness of the capsule membranes, and therefore can also be finely controlled. The thinner the capsule membrane is, the faster the drug release. The initial TTO release rate doubles as the membrane thickness decreases from 4.3 nm to 3.1 nm. In addition, because no surfactant is used in the whole preparation process, the prepared chitosan microcapsules present satisfactory biocompatibility. The results provide valuable guidance for designing and fabricating polymeric microcapsule membranes with controllable nanoscale thickness to enhance their performances in biological and medical applications. • Chitosan microcapsule membranes with controllable nanoscale thickness are developed by a simple microfluidic strategy. • The thickness of capsule membranes can be controlled within 10 nm and accurately regulated at nanoscale. • Drug release behaviors from chitosan microcapsules with nano-membranes can be finely controlled. • The nano-membranes of chitosan microcapsules present both stability and good biocompatibility. [ABSTRACT FROM AUTHOR]